A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC

In tumors, the multi drug resistance phenomenon may occur through the efflux of chemotherapeutic drugs out of cancer cells, impeding their accumulation, and eventually reducing their toxicity. This process is mediated by transporters overexpressed in the plasma membranes of tumor cells, among which...

Descripción completa

Detalles Bibliográficos
Autores principales: Adorni, Maria Pia, Galetti, Maricla, La Monica, Silvia, Incerti, Matteo, Ruffoni, Alessandro, Elviri, Lisa, Zanotti, Ilaria, Papotti, Bianca, Cavallo, Delia, Alfieri, Roberta, Petronini, Pier Giorgio, Bernini, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861803/
https://www.ncbi.nlm.nih.gov/pubmed/36674503
http://dx.doi.org/10.3390/ijms24020989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861803/
https://www.ncbi.nlm.nih.gov/pubmed/36674503
http://dx.doi.org/10.3390/ijms24020989

Ejemplares similares